drugset / Trial / NCT04843319

To Determine an Effective Dose of VERU-100 for the Treatment of Advanced Prostate Cancer

NCT04843319 ↗

Phase 1/2 Terminated 24 enrolled Veru Inc.
NaSingle-groupOpen-labelTreatment

Summary

To determine an effective dose of VERU-100 for the treatment of advanced prostate cancer by assessing its effect on testosterone levels by Day 28 and maintenance through Day 91.

Timeline

Start
2021-06-09
Primary completion
2023-01-19
Completion
2023-01-19

Outcome

Outcome not reported

Stopped: “Study terminated as end points were not achieved at current dose level.”

Drugs

EvaluationDrugModalityDoseRoute
Subject VERU-100 Unknown 2 ml —
Subject VERU-100 Unknown 2.5 ml —
Subject VERU-100 Unknown 3 ml —
Subject VERU-100 Unknown 3.5 ml —